Exiqon A/S
Exiqon calls for ordinary general meeting on 25 March 2014

DGAP-News: Exiqon A/S /

28.02.2014 / 10:08

---------------------------------------------------------------------

Exiqon A/S (NASDAQ OMX Copenhagen: 'EXQ') calls for the ordinary general
meeting to be held on Tuesday 25 March 2014 at 3 pm (CET) at the company's
address, Skelstedet 16, 2950 Vedbaek, Denmark. A copy of the notice with the
complete proposals is attached hereto and can also be seen at www.exiqon.com. 

Additional information
Lars Kongsbak, CEO, phone +45 4566 0888 (cell: +45 4090 2101)
Hans Henrik Chrois Christensen, CFO, phone +45 4566 0888 (cell: +45 4090 2131)

About Exiqon
Exiqon operates in two business segments: Exiqon Life Sciences has established
a position for itself as one of the market's leading providers of research
products for microRNA analysis. Exiqon Diagnostics develops novel molecular
diagnostic tests for stratification of patients, for clinical trials, early
detection of diseases and to help physicians make treatment decisions based on
RNA profiling. Exiqon is listed on NASDAQ OMX in Copenhagen. For more
information about us, please visit www.exiqon.com.
News Source: NASDAQ OMX


End of Corporate News

---------------------------------------------------------------------

28.02.2014 Dissemination of a Corporate News, transmitted by DGAP - a
company of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---------------------------------------------------------------------


Language:    English       
Company:     Exiqon A/S    
 
 
             Denmark       
ISIN:        DK0060077758  
 
 
End of News    DGAP News-Service  
---------------------------------------------------------------------  
255038 28.02.2014